about
TACC1-chTOG-Aurora A protein complex in breast cancerThe functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targetsAurora B -TACC1 protein complex in cytokinesisInternational network of cancer genome projects.TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocationControl of ciliogenesis by FOR20, a novel centrosome and pericentriolar satellite proteinBreast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureIdentification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancerLobular and ductal carcinomas of the breast have distinct genomic and expression profilesMicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.Gene expression profiling of breast cell lines identifies potential new basal markers.Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survivalDe-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGFβ-deficient squamous cell carcinoma from transition zones.Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.Fifteen years of research on oral-facial-digital syndromes: from 1 to 16 causal genes.Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.OFIP/KIAA0753 forms a complex with OFD1 and FOR20 at pericentriolar satellites and centrosomes and is mutated in one individual with oral-facial-digital syndrome.Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes.Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.Genomic analysis of myeloproliferative neoplasms in chronic and acute phases.PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2.Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.Integrated profiling of basal and luminal breast cancers.Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.Mutations of ASXL1 gene in myeloproliferative neoplasms.Chromosome arm 8p and cancer: a fragile hypothesis.Phylogenetic analysis of Ciona intestinalis gene superfamilies supports the hypothesis of successive gene expansions.Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.The Genomic Grade Index predicts post-operative clinical outcome in patients with soft tissue sarcoma.Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.Prognostic score including gene mutations in chronic myelomonocytic leukemia.miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling.An evolutionary history of the FGF superfamily.
P50
Q24299319-A735C1EF-A37C-42C1-BA1C-3A01CB5BBECBQ24304999-7B892EED-D19A-4584-B6B1-4A3544786F4EQ24324208-AC036A43-3E9D-4F6F-A96A-577D8C4FB1E9Q24611474-347E783C-0B35-45D6-A443-790627FEA0DEQ27851480-C05CBF04-2914-47FD-92EF-32D6DD6FE6ACQ28263004-75E4EB51-0ECC-495A-BF35-60E0818CC840Q28589236-0CAC945A-8C5A-418B-84C1-D241C32BBF56Q29622952-0E711BDC-6B77-41F0-BFED-AEE98AE9623AQ30277772-79837976-A09E-42FD-8B03-B06E04AA6080Q33988589-1A5A5440-82A0-4DE9-9D36-37F761B27BCEQ34299430-64C3F1CB-2CAA-4C63-A561-FDB57B4C44D5Q34467687-D16C0904-797E-4DD2-BEA4-08CEB32A5A69Q37528475-61A6F89F-C85C-497E-9904-498A54E948F9Q37656680-F5086AEA-EE09-4E1D-9F0C-97341C30F933Q37694797-890BC52C-10E9-416D-8593-0772E48131CBQ38708251-7DD9E130-FFE7-416F-88FE-D4989D250E48Q39076309-C3A49C7E-7D04-4F9C-92D9-79E6B631C8F8Q39176592-3A0F381D-35BE-4DAF-A4AC-68ED3FE9AA7EQ39346398-CAAC3CD6-2990-4E72-B589-E5141E430B18Q39561464-CEB2B6B3-D6B0-484B-B82B-0FDC0EC66F08Q40127946-15E37ED5-5453-4D58-B9E7-A5D47F1B11DEQ40235769-BCDDD1CF-386F-424E-8ABB-72C25510CA01Q40297853-3F1548EE-2EBC-415A-AE8F-4F9A1102783BQ41177344-13342088-DD3E-4A4C-924F-8C9DAC5FAE6EQ42334362-64208423-F486-4862-8A37-5CAE31740F82Q42493207-69454EA0-581A-4E36-B72E-033D98AC3F5EQ42503309-1A9FB1E3-9BB2-4E4D-AC77-D2614324ED63Q42522755-C0F2A743-2B21-4517-BB32-861FD96B19F3Q42524306-A33E301B-A2E4-4F56-9F98-8E28E2E82455Q43456344-EB3A9C6E-E0CD-4B6C-B00A-03526517F833Q44614687-5E9AD078-858F-4EE9-AF18-DD085D454056Q44813182-5FD35D8C-ECFD-4733-9136-346446AA5852Q46652608-EA8B2532-D541-4449-B57A-8E0AF190562DQ46665893-8914F9D5-CAC0-439F-ABF2-5C3CAE3E65A6Q46905468-15F8998F-3BC9-4B3E-AE01-E8E8A00A1FEAQ47720588-54AFC481-D958-40CD-BCA4-D060C976916BQ48712020-22EF5771-6A35-48BB-B512-772DAD2DCB53Q50976843-A0D77BE1-7409-4301-9E62-AF423DC340E6Q51116863-BEC97EC8-112F-42CB-AEC6-47F99F661D43Q52044502-23E252B2-0D37-444C-9538-AEF10408162A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Birnbaum
@ast
Daniel Birnbaum
@en
Daniel Birnbaum
@es
Daniel Birnbaum
@nl
type
label
Daniel Birnbaum
@ast
Daniel Birnbaum
@en
Daniel Birnbaum
@es
Daniel Birnbaum
@nl
prefLabel
Daniel Birnbaum
@ast
Daniel Birnbaum
@en
Daniel Birnbaum
@es
Daniel Birnbaum
@nl
P106
P31
P496
0000-0001-7920-9883